A Phase I Study of BR108 in Hematological Malignancies
BioRay Pharmaceutical Co., Ltd.
BioRay Pharmaceutical Co., Ltd.
Incyte Corporation
Incyte Corporation
Shanghai EpimAb Biotherapeutics Co., Ltd.
Hangzhou Sumgen Biotech Co., Ltd.
Gilead Sciences
Celularity Incorporated
Takeda
Prolacta Bioscience
Antengene Corporation
Antengene Corporation
Pfizer
GlaxoSmithKline
Prelude Therapeutics
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
MediMergent, LLC
AstraZeneca
Cellphire Therapeutics, Inc.
AbbVie
Fate Therapeutics
Molecular Templates, Inc.
Kiadis Pharma
Genenta Science
Fate Therapeutics
Terumo BCTbio
Kiadis Pharma
Menarini Group
Novartis
Pfizer
SecuraBio
Exact Sciences Corporation
Adaptimmune
Incuron
Gilead Sciences
Novartis
Acrotech Biopharma Inc.
Cellectis S.A.
Novartis
Incyte Corporation
Xian-Janssen Pharmaceutical Ltd.
Fate Therapeutics
EMD Serono
Novartis
Bristol-Myers Squibb
Celgene
Infinity Pharmaceuticals, Inc.
Sanofi
Gilead Sciences
Novartis